| General Information of Drug Metabolite (DM) (ID: DM005741) |
| DM Name |
N-(2-methyl-3-chlorophenyl)-5-hydroxy-anthranilic acid
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Multi-steps Reaction - Glucuronidation; hydroxylation |
GEA-6414
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| GEA-6414 |
DR1613
|
Phase 1/2 |
Parkinsonism |
|
|
| References |
| 1 |
Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
